ASRM Decries Latest Cuts at CDC
Statement attributable to Sean Tipton, Chief Advocacy and Policy Officer
October 15, 2025
For immediate release
Earlier this year, the team that worked on Assisted Reproductive Technologies at the CDC was eliminated. It now appears nearly every employee of the Office of Population Affairs (OPA) has been sidelined by political leadership at HHS. The OPA oversees critical public health programs ranging from teen pregnancy prevention to embryo donation. These cuts will have a detrimental impact on America’s reproductive health.
We are calling on Secretary Kennedy to immediately reverse these devastating cuts.”
For almost a century, the American Society for Reproductive Medicine (ASRM) has been the global leader in multidisciplinary reproductive medicine research, ethical practice, and education. ASRM impacts reproductive care and science worldwide by creating funding opportunities for advancing reproduction research and discovery, by providing evidence-based education and public health information, and by advocating for reproductive health care professionals and the patients they serve. With members in more than 100 countries, the Society is headquartered in Washington, DC, with additional operations in Birmingham, AL. www.asrm.org
For media inquiries regarding this press release contact:
Sean Tipton
ASRM Chief Advocacy and Policy Officer
E: stipton@asrm.org
Anna Hovey
Advocacy Engagement Specialist
E: ahovey@asrm.org
J. Benjamin Younger Office of Public Affairs
726 7th St. SE
Washington, DC 20003
Tel: (202) 863-2494
Press Releases
Check out these press releases as well
National Infertility Awareness Week Highlights Record IVF Births, Growing Demand for Fertility Care
IVF births surpass 100,000 in one year, highlighting demand for fertility care as ASRM urges awareness, reduced stigma, and expanded access nationwide.
ASRM Center for Policy and Leadership Warns Federal Funding Cuts Are Undermining Reproductive Health Infrastructure
Federal funding cuts to NIH, CDC, and FDA threaten reproductive health research, patient safety, and access to care, warns new ASRM policy report.
New Research Links “Forever Chemicals” to Reduced Fertility, Pregnancy Complications
Study finds PFAS “forever chemicals” may harm fertility, raise preeclampsia risk, and increase preterm birth, highlighting urgent reproductive health concerns.
For the First Time, More Than 100,000 Babies Born Through IVF in the U.S. in a Single Year
IVF births in the U.S. surpass 100,000 in 2024, highlighting rising demand, improved safety, and advances in fertility care and reproductive medicine.
The News from ASRM
Latest News
An indispensable news digest for reproductive scientists, clinicians and allied health professionals. The Latest News posts are available to ASRM members in good standing only.
ASRM Press Releases/Bulletins
ASRM Press Releases and Bulletins are published by ASRM's Office of Public Affairs to inform the press and Society members of important recent developments.
Topic Resources
ASRM Center for Policy and Leadership Warns Federal Funding Cuts Are Undermining Reproductive Health Infrastructure
Federal funding cuts to NIH, CDC, and FDA threaten reproductive health research, patient safety, and access to care, warns new ASRM policy report. View the Press Release
The U.S. Federal Government and Reproductive Health
The Impact of Federal Funding Cuts on Patients, Providers, and the Field of Reproductive Medicine. View the Advocacy Resource
American Society for Reproductive Medicine Responds to TrumpRx Announcement, Says IVF Access Requires More Than Lower Drug Prices
ASRM has responded to the latest announcement about TrumpRx and its impact on IVF treatments. View the Press Release
ASRM Responds to Speaker Johnson’s Stripping of Fertility Coverage for America’s Military Personnel
ASRM condemns Speaker Johnson’s removal of TRICARE fertility coverage from NDAA, urging action to restore IVF benefits for U.S. military families. View the Press Release
ASRM Inaugural INNOVATE
ASRM INNOVATE spotlighted the energy of innovation in reproductive medicine and how collaboration will shape the future of fertility and reproductive health. Read about INNOVATE
Improving access to care and delivery to marginalized and vulnerable populations: a committee opinion (2025)
ASRM committee opinion on reducing infertility care disparities, outlining barriers and actionable strategies to improve equitable access. View the opinion
Key Abstracts Presented at the ASRM 2025 Scientific Congress & Expo
ASRM 2025 reveals support for IVF access, wildfire smoke's fertility risks, and how insurance mandates improve outcomes in reproductive health care. View the Press Release
American Society for Reproductive Medicine Reacts to White House Announcement on IVF Coverage
ASRM applauds the White House’s first steps toward IVF access but underscores that true equity demands mandatory insurance coverage. View the Press Release
ASRM Decries Latest Cuts at CDC
ASRM condemns sweeping staff cuts at CDC and HHS, warning they threaten reproductive and public health. View the Press Release
Preparing Experts in Reproductive Medicine to Engage Decisionmakers
ASRM’s PRIMED program trains reproductive health experts to advocate for evidence-based policy, empowering professionals to engage lawmakers and advance care access. ASRM PRIMED Program continues mission
Assisted Reproductive Technology (ART) Oversight: Lessons for the United States from Abroad
A comprehensive analysis of global Assisted Reproductive Technology (ART) regulations, comparing policies, accessibility, and ethical considerations in various countries. View the advocacy resource
ASRM Announces FY25 Patient Advocacy Grant Awardees
Congratulations to the Newest Grant Recipients! View more information about the patient advocacy grant
What support for IVF looks like
Bipartisan support for IVF, that is responsible for the birth of over 2% of all babies born in the USA each year, will ensure that families continue to grow. View the advocacy resource
It takes more than one
Why IVF patients often need multiple embryos to have a baby View the advocacy resource
Oversight of IVF in the US
In the US, medical care is regulated by a complex and comprehensive network of federal and state regulations and professional oversight. View the advocacy resource
Ethical considerations for telemedical delivery of fertility care: an Ethics Committee opinion (2024)
Telemedicine has the potential to increase access to and decrease the cost of care. View the Committee Opinion
Cross-border reproductive care: an Ethics Committee opinion (2022)
Cross-border reproductive care is a growing worldwide phenomenon, raising questions about why assisted reproductive technology patients travel for care. View the Ethics Committee Document
Reproductive and infertility care in times of public health crises: an Ethics Committee opinion (2022)
Public health crises often require a framework shift in which patient autonomy is balanced with the need to safeguard the health of the community. View the Committee opinion
Access to fertility treatment irrespective of marital status, sexual orientation, or gender identity: an Ethics Committee opinion (2021)
Individuals and couples should have access to fertility services irrespective of marital status, sexual orientation, or gender identity. View the Committee Opinion
Disparities in access to effective treatment for infertility in the United States: an Ethics Committee opinion (2021)
In the United States, economic, racial, ethnic, geographic, and other disparities prevent access to fertility treatment and affect treatment outcomes. View the Committee Opinion
Exploring Access to Care for Marginalized Communities Course
Enhance your skills and contribute to reducing healthcare disparities for marginalized communities. Learn more about the Exploring Access to Care for Marginalized Communities Course
Access to Care Special Interest Group (ATCSIG)
The Access To Care Special Interest Group's purpose is to foster the growth of knowledge among the ASRM membership and the medical community regarding the unmet needs that exist today in access to reproductive care Learn more about the Special Interest Group
